Parecoxib inhibits esophageal squamous cell carcinoma progression via the PDK1-AKT pathway.

Huang HM, Huang XY, Wu SP, Chen CK, He XH, Zhang YF

DOI: 10.1186/s11658-022-00324-w
Published: 2022 Mar 19
Container: Cellular & molecular biology letters
Publisher: Not recorded
Open access: yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s11658-022-00324-w,
  title = {Parecoxib inhibits esophageal squamous cell carcinoma progression via the PDK1-AKT pathway.},
  author = {Huang HM and Huang XY and Wu SP and Chen CK and He XH and Zhang YF},
  year = {2022},
  journal = {Cellular \& molecular biology letters},
  doi = {10.1186/s11658-022-00324-w},
  url = {https://doi.org/10.1186/s11658-022-00324-w}
}

RIS

TY  - JOUR
TI  - Parecoxib inhibits esophageal squamous cell carcinoma progression via the PDK1-AKT pathway.
AU  - Huang HM
AU  - Huang XY
AU  - Wu SP
AU  - Chen CK
AU  - He XH
AU  - Zhang YF
PY  - 2022
JO  - Cellular & molecular biology letters
DO  - 10.1186/s11658-022-00324-w
UR  - https://doi.org/10.1186/s11658-022-00324-w
ER  -

APA

HM, H., XY, H., SP, W., CK, C., XH, H., & YF, Z. (2022). Parecoxib inhibits esophageal squamous cell carcinoma progression via the PDK1-AKT pathway.. Cellular & molecular biology letters. https://doi.org/10.1186/s11658-022-00324-w

Source records

pubmed · retrieved 2026-11-10T14:43:16.713Z